Frank, D., Jayavelu, A. K., Wei, L., Al-Matary, Y., Patnana, P. K., Nimmagadda, S. C., Heuser, M., Thol, F., Goehring, G.,
Thomale, J., Pfaus, A., Rad, R., Jeremias, I., Vick, B., Hoffmann, S., Stoelzel, F., Dill, C., Altmann, H., Kunadt, D., Schliemann,
C., Mikesch, J.-.-H., Arteaga-Paz, M. F., Berdel, W., & Khandanpour, C. (2020).
A single nucleotide polymorphism of the transcription factor Growth Factor Independence 1 (GFI1) accelerates AML evolution
and sensitizes AML cells to treatment with DNA repair inhibitors. Oncology Research and Treatment,
43(SUPPL 4), 36-37.
